NEW YORK EYE AND EAR INFIRMARY
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $3.2M
- Transactions
- 152
- Companies
- 24
- Average per transaction
- $21,363
Who reported the payments
| AbbVie | $2,039,241 |
| Novartis | $633,000 |
| Shire North American Group Inc | $200,000 |
| Regeneron | $148,350 |
| Cochlear Americas | $40,493 |
| Advanced Bionics, LLC | $36,635 |
| Alcon | $25,500 |
| Johnson & Johnson Surgical Vision, Inc. | $21,000 |
| Med-el Corporation | $17,220 |
| Carl Zeiss Meditec, Inc. | $16,720 |
| Stryker | $12,244 |
| Argenx US, Inc. | $10,670 |
| Cook Incorporated | $10,260 |
| Nidek CO., LTD. | $9,000 |
| Medline Industries LP | $6,301 |
| Boehringer Ingelheim | $5,085 |
| Amgen | $5,000 |
| Glaukos Corporation | $2,500 |
| Aerie Pharmaceuticals, Inc. | $2,500 |
| Olympus America Inc. | $2,149 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | $1,500 |
| Medtronic | $929 |
| Baxter Healthcare | $698 |
| Leica Microsystems Inc. | $196 |